AbbVie’s blockbuster drug Humira finally loses its 20-year, $200 billion monopoly
(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira — an injectable treatment
Read More(Leslie Walker and Dan Gorenstein for NPR) After 20 years and $200 billion in revenue, Humira — an injectable treatment
Read More(By Jordan Rau for Kaiser Health News) After the nursing home where Leann Sample worked was bought by private investors,
Read More(By Jakob Emerson for Becker’s Hospital Review) A bipartisan group of senators are once again pushing for new regulations around
Read More(By Zeke Miller and Amanda Seitz — Associated Press published by STAT on January 30, 2023) WASHINGTON — President Joe
Read More(By Sarah Jane Tribble for Kaiser Health News) When the covid-19 pandemic hit, Dr. Corey Siegel was more prepared than
Read More(By Fred Schulte for Kaiser Health News) Medicare Advantage plans for seniors dodged a major financial bullet Monday as government
Read More(By Chris Lee for Kaiser Family Foundation Published: Jan 26, 2023) The share of people who say they have had
Read More(Source – www.cms.gov) CMS has a number of resources available to help people with Medicare understand the reduced drug costs
Read More(By Jakob Emerson for Becker’s Hospital Review) Diabetic patients that were forced to enroll in a high-deductible health plan by
Read More(Source – news. va.gov) In February 2022, VA Secretary Denis McDonough issued a challenge to VA staff and partners: place
Read More